Qureight

Qureight is an AI-powered imaging CRO that accelerates drug development. It provides enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

Claim this tool

3Views

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is Qureight?

Qureight is a tech-first, AI-powered imaging Contract Research Organization (CRO) dedicated to accelerating the impact of new life-saving therapies for lung and heart disease. The platform delivers its suite of products through a proprietary data and imaging curation system, enabling the analysis of clinical imaging and healthcare data. Qureight offers automated image management and AI analysis in therapeutic areas such as Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Hypertension, and Bronchiectasis. Its offerings include global imaging CRO services, AI-powered endpoints and analytics with proprietary lung image biomarkers (Lung8™, Air8™, Fibr8™, Glass8™, Vascul8™), and data science products leveraging large real-world datasets for synthetic control arms and early drug development support.

Best used for

Ideal for biopharma companies and researchers who need to accelerate clinical trials, analyze complex imaging data for lung and heart diseases, and develop new therapies faster. Especially valuable for leveraging AI-powered biomarkers and real-world data to improve trial design and efficacy assessment.

Common actions

accelerate drug development

analyze clinical imaging

track treatment response

predict disease progression

support clinical trials

research

Capabilities

Key features

Automated image management
AI image analysis
Proprietary lung biomarkers
Data curation platform
Synthetic control arms
Clinical trial read-outs
Endpoint discovery

Target Audience

clinical researcherspharmaceutical companiesbiotechnology firmscontract research organizations

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Contact for Pricing

FAQs

What therapeutic areas does Qureight specialize in?

Qureight specializes in lung and heart diseases, with specific expertise in Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Hypertension, and Bronchiectasis. Their AI-powered platform is designed to analyze imaging and healthcare data within these complex therapeutic areas.

How does Qureight's AI-powered platform assist in clinical trials?

Qureight's platform provides automated image management, AI analysis, and proprietary lung image biomarkers (e.g., Lung8™, Fibr8™) to track treatment response, predict disease progression, and assess baseline disease severity. This helps accelerate patient inclusion and evaluate participants rapidly.

Can Qureight provide synthetic control arms for clinical trials?

Yes, Qureight has commercial access to large real-world datasets in IPF, PPF, PH, and Bronchiectasis. They use this data to offer synthetic control arms, enabling robust efficacy assessment in trials where traditional placebo arms are impractical, unethical, or inefficient.

Trending

Subcategories trending in Wellness & Lifestyle

Clinical & Healthcare Pro Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking

Trending

Also listed in

This tool also appears in

Research & Education › Academic Research

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce